XL-ing at Induction of Apoptosis in Kidney Cancer through Inhibition of BCL-XL.
Naitao WangAbraham Ari HakimiJuliet ChenPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Through analysis of the cancer dependency map of CRISPR and short hairpin RNA datasets, the antiapoptotic BCL-XL was found to be a selective dependency in kidney cancer. Among kidney cancers, BCL-XL inhibition is most active in those with a mesenchymal gene signature, which portends a poor prognosis and response to current therapies. See related article by Grubb et al., p. 4689.